Richard Scranton MD Mph
About Richard Scranton MD Mph
Richard Scranton, MD, MPH, serves as the President of Global Product Development at Lyndra Therapeutics. He has over 21 years of experience in clinical research and epidemiology, with a focus on chronic diseases and regulatory affairs.
Current Role at Lyndra Therapeutics
Richard Scranton serves as the President of Global Product Development at Lyndra Therapeutics, a position he has held since 2023. In this role, he is responsible for overseeing the development of innovative therapeutic products. Lyndra Therapeutics is located at 65 Grove Street, Suite 301, Watertown, MA 02472. His leadership focuses on advancing the company's mission to improve patient outcomes through innovative delivery systems.
Education and Expertise
Richard Scranton earned his Master of Public Health (MPH) degree from Harvard T.H. Chan School of Public Health, specializing in Epidemiology and Clinical Research, from 2000 to 2002. He also holds a Doctor of Medicine (MD) degree from East Tennessee State University James H. Quillen College of Medicine, which he completed from 1990 to 1994. He has over 21 years of expertise in pharmaco-epidemiologic research, clinical epidemiology, health services research, and clinical trials research.
Previous Experience at Pacira BioSciences, Inc.
Before joining Lyndra Therapeutics, Richard Scranton held several key positions at Pacira BioSciences, Inc. He served as Chief Medical Officer from 2018 to 2021 and as Chief Scientific Officer from 2017 to 2020. Additionally, he was Vice President of Clinical and Scientific Affairs from 2013 to 2017 and Executive Medical Director from 2011 to 2020. His roles involved overseeing clinical development and scientific strategy.
Background in Military Medicine
Richard Scranton served in the US Navy as a Lieutenant Commander in the Medical Corps from 1994 to 2000. This experience provided him with a strong foundation in medical practice and leadership within a military context, contributing to his comprehensive understanding of healthcare delivery in diverse settings.
Specialization in Health Outcomes Research
Richard Scranton has a particular focus on health outcomes research, including patient-reported outcomes and chronic diseases such as cardiovascular conditions, diabetes, and obesity. His work emphasizes the importance of understanding the impact of medical interventions on patients' lives and health status.